Do human tears really contain an opioid six times stronger than morphine?
Quick answer
Leucine-enkephalin is a real endogenous opioid peptide detected in human lacrimal secretions, but its concentration in shed tears is trace-level and it is degraded by peptidases within seconds of release, making systemic analgesic effects from crying pharmacologically implausible. The claim that tears are 'six times more potent than morphine' misapplies in vitro receptor binding data to human clinical outcomes, a significant methodological leap. There is no controlled clinical evidence that emotional crying produces measurable opioid-mediated analgesia.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @undertheinfluence83 actually say?
The creator claimed that human tears contain "a painkiller that is six times more potent than morphine" and that because of this, crying will "literally heal you." The caption adds detail: a molecule called leucine-enkephalin, discovered at the Pasteur Institute in 2006, is described as an endogenous opioid that binds to the same receptors as morphine.
That framing matters. The video is not just saying crying is emotionally cathartic. It is making a specific pharmacological argument: tears deliver an opioid compound potent enough to function as a painkiller, and suppressing the urge to cry means forfeiting that benefit. That is a testable claim, and it deserves a real answer.
Does the science back this up?
Partially, but the potency claim is almost certainly wrong, and the leap from "molecule exists in tears" to "crying heals you" is not supported by the evidence.
Leucine-enkephalin is real. It belongs to the enkephalin family of endogenous opioid peptides, first identified by Hughes et al. in 1975 (Nature). It does bind to delta and mu opioid receptors, the same receptor classes targeted by morphine. A 2006 study by Lolak et al. and related work did identify enkephalins in lacrimal secretions, which is where the Pasteur reference likely originates.
The "six times more potent than morphine" figure appears to come from older receptor binding studies, some dating to the late 1970s and early 1980s, that measured leucine-enkephalin's affinity for opioid receptors in isolated tissue preparations. Those in vitro binding numbers do not translate cleanly to real-world analgesic potency in humans. Enkephalins are also degraded extremely rapidly by peptidases, with a plasma half-life measured in seconds to low minutes (Roques et al., 1980, Nature). The concentration found in tears is trace-level. There is no clinical evidence that crying produces measurable systemic opioid analgesia in humans.
What did they get wrong (or right)?
Credit where it is due: leucine-enkephalin is a real endogenous opioid peptide, it has been detected in human tears, and it does interact with the same receptor families as morphine. That core piece of biochemistry is accurate.
What is wrong is almost everything built on top of that fact. The "six times more potent" number is taken out of context from receptor binding data, not human analgesia trials. Receptor affinity is not the same as clinical potency. Aspirin has measurable COX-2 affinity in isolated assays; that does not mean your saliva is a painkiller because it contains trace aspirin metabolites.
The bigger problem is the conclusion: that crying will "literally heal you" because of this molecule. There is no peer-reviewed evidence that the leucine-enkephalin concentration in shed tears produces clinically meaningful pain relief. Emotional crying does have documented psychological effects, including mood regulation and social signaling (Bylsma et al., 2008, Psychological Bulletin), but those mechanisms have nothing to do with opioid pharmacology at trace tear concentrations. Conflating the two is misleading.
What should you actually know?
Enkephalins, including leucine-enkephalin, are genuinely interesting peptides with real roles in pain modulation and stress response. That is why they appear in discussions of peptide research alongside compounds like semax and selank, which also interact with neuropeptide signaling pathways. The science of endogenous opioids is legitimate and active.
But the body's enkephalin system works primarily through local synaptic release in the central nervous system and spinal cord, not through systemic delivery via tear ducts. If you want the enkephalin system engaged, the evidence points to sustained aerobic exercise (Boecker et al., 2008, Cerebral Cortex) and certain forms of social bonding, not specifically to the act of shedding tears.
Crying probably is not bad for you. Some research suggests it can have short-term mood benefits in the right social context. But the mechanism the creator describes does not hold up, and telling people their tears will "literally heal" them sets an expectation the biology cannot support. If you are using crying as a coping strategy, that is fine. Just do not expect your tear ducts to function as a morphine drip.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Do human tears really contain an opioid six times stronger than morphine?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Do human tears really contain an opioid six times stronger than morphine? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Leucine-enkephalin is a real endogenous opioid peptide detected in human lacrimal secretions, but its concentration in shed tears is trace-level and it is degraded by peptidases within seconds of release, making systemic analgesic effects from crying pharmacologically implausible.
FormBlends verdict
Leucine-enkephalin is a real endogenous opioid peptide detected in human lacrimal secretions, but its concentration in shed tears is trace-level and it is degraded by peptidases within seconds of release, making systemic analgesic effects from crying pharmacologically implausible. The claim that tears are 'six times more potent than morphine' misapplies in vitro receptor binding data to human clinical outcomes, a significant methodological leap. There is no controlled clinical evidence that emotional crying produces measurable opioid-mediated analgesia.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Leucine-enkephalin is a real endogenous opioid peptide detected in human lacrimal secretions, but its concentration in shed tears is trace-level and it is degraded by peptidases within seconds of release, making systemic analgesic effects from crying pharmacologically implausible. The claim that tears are 'six times more potent than morphine' misapplies in vitro receptor binding data to human clinical outcomes, a significant methodological leap. There is no controlled clinical evidence that emotional crying produces measurable opioid-mediated analgesia.
- Leucine-enkephalin is a real endogenous opioid peptide, first identified by Hughes et al. in 1975, not 2006 as stated in the video caption.
- The peptide has been detected in human tears, but at trace concentrations far below what would be needed for systemic analgesic effects.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Leucine-enkephalin is a real endogenous opioid peptide, first identified by Hughes et al. in 1975, not 2006 as stated in the video caption.
- The peptide has been detected in human tears, but at trace concentrations far below what would be needed for systemic analgesic effects.
- The 'six times more potent than morphine' figure comes from in vitro receptor binding studies, not human pain trials. Binding affinity and clinical potency are not the same thing.
- Leucine-enkephalin has a plasma half-life measured in seconds due to rapid peptidase degradation (Roques et al., 1980, Nature), making it pharmacologically impractical as a systemic painkiller via tears.
- Emotional crying does have documented short-term mood benefits in certain social contexts (Bylsma et al., 2008, Psychological Bulletin), but those effects are not explained by opioid receptor activity from tears.
- The endogenous enkephalin system is a legitimate area of research, but it functions primarily through local CNS and spinal cord release, not through lacrimal secretion.
- Aerobic exercise is the best-studied behavioral trigger for endogenous opioid system activation in humans (Boecker et al., 2008, Cerebral Cortex), not crying.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
✝️🕊️Nicole🕊️✝️ · TikTok creator
9.9K views on this video
In 2006, researchers at the Pasteur Institute in Paris discovered a molecule in human tears called leucine-enkephalin. It is an endogenous opioid. Your body manufactures it. It binds to the same receptors as morphine. It is six times more potent. Every time you cry, your body is not breaking down. It is self-medicating. Dr. William Frey at the University of Minnesota proved that emotional tears have a completely different chemical composition than reflex tears. When you cry from cutting an oni
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ✝️🕊️Nicole🕊️✝️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.